'Vitamin B17': Killing more than cancer.

Ingrid Berling Jared A Brown Brendan Toy

Published in: Emergency medicine Australasia : EMA (2024)

There is a significant burden of concern generated from the misuse of cyanogenic glycoside products for cancer prevention and treatment, which can result in hospital admission carrying significant health risk and expenditure.

Keyphrases

health risk
papillary thyroid
squamous cell
healthcare
heavy metals
squamous cell carcinoma
childhood cancer
risk factors
young adults
adverse drug
acute care